Friday, January 25, 2019

Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats

Cyclosporin A (CsA) is a promising therapeutic drug for myocardial ischemia reperfusion injury (MI/RI) because of its definite inhibition to the opening of mitochondrial permeability transition pore (mPTP). Ho...

from Most Recent Articles: Journal of Nanobiotechnology http://bit.ly/2UeSKAL
via IFTTT

No comments:

Post a Comment